Mexiletine: A Comprehensive Guide
Mexiletine Hydrochloride is a versatile medication that has gained attention in the pharmaceutical industry for its therapeutic applications and potential as an active pharmaceutical ingredient (API).
Whether you’re an API importer, a medicine manufacturer, or a compounding pharmacy, understanding Mexiletine’s properties, uses, and considerations is crucial for optimizing its use in your operations.
This guide is designed for pharmaceutical procurement specialists, compounding pharmacists, and formulation scientists. We are covering pharmacology, emerging applications, and critical supply chain strategies to ensure you never have to tell a patient, “We can’t get it.”
What is Mexiletine?
Mexiletine hydrochloride (CAS 5370-01-4) is an orally active class IB antiarrhythmic agent.
Chemically, it is a local anesthetic structurally similar to lidocaine, but with a distinct advantage: where lidocaine must be injected, Mexiletine is effective when taken by mouth.
It appears as a white to off-white crystalline powder that is freely soluble in water and alcohol, making it a favorite among compounding pharmacies that need to prepare oral suspensions or custom capsules. For the API buyer, “freely soluble” translates to fewer formulation headaches during manufacturing.
But here is the reality: In the commercial pharmaceutical world, many branded and generic versions (E.g., Mexitil®) were technically discontinued in the late 2000s and early 2010s due to commercial decisions and supply chain consolidation.
However—and this is critical—the raw API is very much alive and in demand.
The discontinuation of finished products by major pharma giants opened the door for compounding pharmacies and specialized manufacturers to fill the gap using high-grade APIs.
What Are Mexiletine Brand Names
For procurement professionals, knowing trade names helps you track a drug’s legacy.
Historically, Mexiletine was marketed under the brand name Mexitil® by Boehringer Ingelheim.
However, the landscape today is dominated by generics. When searching for suppliers, you will encounter the API listed under various manufacturers, including Teva, Lannett, Sun Pharma, Amneal, and Rising Pharma.
For our international buyers, you might also see it as Namuscla® (specifically dosed at 167mg for myotonia) or Mexitilen®.
For veterinary lines, it may be labeled under Myovek® or Ritalmex®. When ordering via API, always use the chemical name “Mexiletine Hydrochloride USP/EP.”
What is Mexiletine Used For? (Mexiletine Uses)
Primary Indication: Ventricular Arrhythmias
The gold standard remains the treatment of documented life-threatening ventricular arrhythmias, such as sustained ventricular tachycardia.
It is specifically indicated when the physician deems the rhythm serious enough to warrant intervention. It suppresses premature ventricular contractions (PVCs) effectively in 25% to 79% of patients.
Off-Label & Emerging Uses (The Growth Driver)
This is where the market is shifting.
Myotonic Dystrophy: The FDA has granted Mexiletine Orphan Drug Designation for myotonic dystrophy. It alleviates muscle stiffness and delayed relaxation (myotonia) by stabilizing skeletal muscle cell membranes. Recent Phase 3 trials are exploring a prolonged-release (PR) version specifically for this neuromuscular disorder.
Chronic Pain & Neuropathy: It plays a role in managing peripheral neuropathy and chronic pain syndromes, although this is secondary due to its side effect profile.
Veterinary: Widely used off-label in dogs to manage chronic ventricular arrhythmias that lidocaine alone cannot control.
Mechanism of Action: How Mexiletine Works?
Mexiletine inhibits sodium ion channels in cardiac cells, which are essential for the generation and propagation of electrical impulses.
By blocking these channels, Mexiletine:
- Reduces the excitability of cardiac cells, preventing abnormal electrical activity.
- Slows the conduction of electrical impulses in the heart, which helps restore a normal rhythm.
At the cellular level, Mexiletine is a sodium channel blocker (Class IB). Here is the breakdown that procurement and R&D teams appreciate:
The heart’s rhythm relies on electrical impulses.
Mexiletine inhibits the inward sodium current (Phase 0 of the action potential). Slowing down the rate of depolarization reduces the excitability of the cardiac tissue. Unlike some other antiarrhythmics, Mexiletine has a “rate-dependent” effect—it affects rapidly firing cells (arrhythmias) more than normally functioning cells.
Why this matters for manufacturers: Because of this specific mechanism, Mexiletine has minimal effect on normal sinus node function or AV conduction in healthy tissue. It is a “precision tool” for ventricular issues, which makes it a staple in emergency and chronic care settings.
How Long Does It Take for Mexiletine to Work?
The onset of action for Mexiletine depends on the formulation and the condition being treated:
- Immediate-Release Capsules: Mexiletine typically starts working within 1-2 hours after ingestion.
- Sustained-release formulations are designed to provide a controlled release of the medication over a more extended period, with effects lasting several hours.
For ventricular arrhythmias, it may take several days of consistent dosing to achieve the desired effect.
Patients should follow their healthcare provider’s instructions carefully to ensure optimal results.
Can Mexiletine Cause Weight Gain?
It is a specific question often asked by patients, but it has a surprising answer for the clinical team.
Generally, no. Weight gain is not listed as a side effect of Mexiletine. In fact, recent research suggests the opposite.
A study on the effects of sodium channel blockers on body weight indicated that Mexiletine may decrease body weight and waist circumference, potentially by reducing visceral fat.
If a patient experiences weight gain while on Mexiletine, it is likely due to fluid retention from underlying congestive heart failure, not the drug itself.
Pharmaceutical manufacturers should note that sudden weight gain is a sign that warrants monitoring the patient’s cardiac output, not a direct API reaction.
Does Mexiletine Lower Blood Pressure?
The short answer is yes, potentially, but it is usually mild.
Mexiletine has a negative inotropic effect (it slightly weakens the heart’s pumping strength).
Consequently, it can cause hypotension (low blood pressure), particularly in patients with pre-existing low blood pressure or severe congestive heart failure.
It is a critical precaution for compounding pharmacists and manufacturers: the API is contraindicated in patients with cardiogenic shock.
Does Mexiletine Lower Heart Rate?
Yes. As an antiarrhythmic, it normalizes the heart rhythm.
It can cause bradycardia (sinus bradycardia) or exacerbate existing conduction issues, such as AV heart block.
However, unlike beta-blockers, Mexiletine’s effect on heart rate results from stabilizing the electrical system rather than purely blocking adrenaline.
For procurement, this means the API is potent; the dosage must be strictly controlled to avoid excessively lowering heart rate, especially in elderly patients.
Can Mexiletine Capsules Be Opened?
It is a vital question for compounding pharmacists and caregivers.
Standard capsules: It is generally recommended to swallow Mexiletine capsules whole, with ample liquid (preferably 250 mL), while upright. The capsule shell protects the drug and ensures it reaches the small intestine for optimal absorption.
Compounding application: However, because Mexiletine HCl is freely soluble in water and alcohol, pharmacists can open the capsules to create extemporaneous oral suspensions. The International Journal of Pharmaceutical Compounding has validated a 10-mg/mL oral suspension formulation.
Warning for patients: You should not crush or chew the granules unless directed by a compounder who has specifically prepared the medication in a soft food vehicle. The bitter taste is off-putting, and crushing standard extended-release capsules (though rare) could dump the full dose at once.
Why Was Mexiletine Discontinued?
It is the billion-dollar question for the supply chain.
The original brand, Mexitil (Boehringer Ingelheim), was discontinued in many markets (e.g., the UK NHS officially stopped listing it in 2008).
The FDA databases list several NDAs for Mexiletine Hydrochloride capsules as “Discontinued” (Not for safety reasons, but for commercial reasons).
Why did this happen?
Generic Erosion: Once generics hit the market, the brand’s profit margins evaporated.
Supply Chain Fragility: In the 2020s, manufacturers such as Teva and Lannett reported shortages due to delays in sourcing the active pharmaceutical ingredient.
Safety Profile: While effective, the side effects (nausea, dizziness) made it a second-line agent, reducing commercial volume.
The Result: The discontinuation of the finished product has created a booming demand for the raw mexiletine API.
Compounding pharmacies and specialty manufacturers are now the primary sources, requiring a steady stream of high-purity Mexiletine HCl powder.
Mexiletine Side Effects
For formulation scientists, the side effect profile dictates the delivery method.
Gastrointestinal (Most Common): Nausea, vomiting, heartburn, and abdominal pain occur in up to 12% of patients. This is why we recommend taking the drug with food or an antacid.
Neurological (Second Most Common): Dizziness (8%), tremors (often starting in the hands), ataxia, and insomnia.
Cardiac (Serious): Proarrhythmia (worsening of the heart rhythm), hypotension, bradycardia, and AV block.
Hypersensitivity: Rare but serious cases of DRESS syndrome (Drug Reaction with Eosinophilia and Systemic Symptoms) have been reported.
Mexiletine Dose and Administration
The dosage of Mexiletine depends on the patient’s condition, tolerance, and response to treatment.
For the manufacturer and compounder, dosing is typically based on the HCl salt.
Note that 100 mg of Mexiletine hydrochloride is equivalent to 83.31 mg of Mexiletine base.
Standard Adult Dose: 200 mg to 300 mg every 8 hours.
Loading Dose (Rapid Control): 400 mg initially, followed by 200 mg in 8 hours.
Maximum Dose: 1,200 mg daily (400 mg every 8 hours).
Titration: A minimum of 2-3 days between dose adjustments is recommended.
It’s crucial to follow the prescribed dosage and instructions provided by your healthcare provider.
Adjustments may be necessary based on the patient’s condition and any side effects experienced.
Mexiletine Precautions and Drug Interactions
Procurement and compounding staff must verify patient medication lists.
Contraindications:
Cardiogenic shock
Second- or third-degree AV block (without a pacemaker)
Metabolism (CYP450): Mexiletine is metabolized primarily by CYP1A2 and CYP2D6.
Inhibitors (Increase toxicity): Ciprofloxacin, Fluvoxamine, Propafenone. If combined, reduce the Mexiletine dose.
Inducers (Reduce efficacy): Rifampin, Phenytoin.
Theophylline: Mexiletine significantly increases Theophylline levels, requiring a 50% reduction in Theophylline dose to avoid toxicity.
Is There Mexiletine Veterinary?
Absolutely.
The veterinary market is a substantial driver of API demand.
While not FDA-approved for animals in many countries (used “extra-label”), Mexiletine is a staple in cardiology veterinary clinics.
It is used to treat chronic ventricular arrhythmias in dogs, particularly Boxers with Arrhythmogenic Right Ventricular Cardiomyopathy (ARVC). It is often used in conjunction with Sotalol or Atenolol.
However, its use in veterinary medicine is not yet widespread, and more research is needed to establish safety and efficacy in animals.
What are Mexiletine for dogs?
While Mexiletine is not yet approved for veterinary use in many regions, it has shown promise in treating certain cardiac conditions in dogs, particularly arrhythmias.
So for our canine patients, Mexiletine is a lifesaver.
The mechanism of action is identical to that in humans (sodium channel blockade), but the doses differ.
Canine Dosage: Typically 4-6 mg/kg orally every 8 hours.
Efficacy: It has a reported favorable outcome rate of approximately 85% for suppressing ventricular tachycardia in dogs.
Compounding need: Dogs cannot easily swallow large human capsules. This is a prime opportunity for compounding pharmacies to create flavored suspensions or mini-capsules from the bulk API powder.
However, its use in veterinary medicine should be undertaken only under the guidance of a licensed veterinarian, as it is not yet standardized.
In dogs, mexiletine addresses:
- Arrhythmias: Stabilize rhythm post-cardiac injury.
- Dosage: 4–8 mg/kg every 8–12 hours. Side effects mirror humans (vomiting, lethargy), requiring close monitoring.
Global Sourcing Tips for Mexiletine API
If you are a pharmaceutical manufacturer reading this, you know the market is tight. Here is how to win:
Verify the Certificate of Analysis (CoA): Do not accept vague claims. You need USP/EP grade with specific impurity profiling.
Check the DMF (Drug Master File): The best suppliers (like AGC Pharma, Octagon Chemical, or specialized CDMOs) hold a DMF with the FDA or EDQM. This drastically speeds up your regulatory filing.
Watch the Supply Chain: Over 60% of formulation delays are linked to poor API sourcing. Ensure your supplier has GMP certification from a recognized authority (e.g., China FDA, WHO, or EU GMP).
Request a Sample: Always request a 5g or 10g sample for HPLC testing in your lab before ordering metric tons.
Compounding Pharmacy Guidelines for Mexiletine Formulations
For the compounders reading this: The commercial capsules are becoming harder to stock. You need to pivot to the raw API.
Oral Suspension (10 mg/mL): Because Mexiletine HCl is freely soluble in water, you can create a stable suspension using a 1:1 mixture of Ora-Plus and Simple Syrup. The formulation is stable for up to 30 days when refrigerated.
Flavoring: The API has a slightly bitter taste and a numbing effect (similar to lidocaine). Do not use flavors that rely on sweetness alone; use chocolate or peanut butter (for veterinary use) or mint (for human use) to mask the bitterness.
Capsule Filling: Use a diluent, such as microcrystalline cellulose, to ensure uniform distribution in low-strength capsules (50 mg or 100 mg).
Cost-Effective Bulk Purchasing Strategies for Mexiletine API Importers
Strategic Volume Commitments: Negotiate tiered pricing based on volume with your mexiletine suppliers. Consider annual contracts with quarterly deliveries to secure prices and ensure a stable supply.
Consolidated Shipping: Use freight forwarders experienced in pharma logistics to consolidate shipments and optimize Incoterms (e.g., FCA over EXW).
Duty Optimization: Leverage Free Trade Agreements (FTAs) (e.g., USMCA if applicable) and ensure correct HS code classification for API duty rates.
Minimize Waste & Inventory Costs: Implement just-in-time (JIT) inventory with buffer stock. Monitor expiry dates closely.
Total Cost Analysis: Look beyond unit price. Factor in shipping, import duties, insurance, testing costs, storage, and potential quality failure costs.
Supplier Partnerships: Establish long-term relationships with reliable mexiletine manufacturers to secure better pricing, priority during shortages, and collaborative problem-solving.
Mexiletine Emerging Applications
Neuropathic Pain Management: Significant focus beyond cardiac use. Mexiletine shows promise for Diabetic Neuropathy, Chemotherapy-Induced Peripheral Neuropathy (CIPN), and Fibromyalgia due to its sodium channel-blocking properties.
Myotonia (Non-Dystrophic): Established use for myotonia congenita (Thomsen/Becker) and paramyotonia congenita to reduce muscle stiffness. Ongoing research optimizes dosing.
Potential in CNS Disorders: Early research explores the use of Mexiletine for ataxia (e.g., Episodic Ataxia Type 2) and neuroprotection in specific contexts, although the evidence is preliminary.
Rare Channelopathies: Mexiletine has been investigated for other sodium/potassium channel mutations causing neurological symptoms.
Key Considerations: Most emerging uses are off-label. Robust clinical trial data are still evolving. Efficacy varies significantly between conditions and individuals. Close monitoring for side effects remains critical.
Conclusion
Mexiletine is a valuable medication with significant applications in treating ventricular arrhythmias and other cardiac conditions.
Its mechanism of action, safety profile, and versatility make it a preferred option in the pharmaceutical industry.
For API importers, medicine manufacturers, and compounding pharmacies, understanding the properties, uses, and potential concerns of Mexiletine is essential for optimizing its use in your operations.
Whether you’re sourcing Mexiletine as an API for manufacturing or exploring its potential in specialized applications, staying informed about its therapeutic benefits and precautions will help you make informed decisions.
By leveraging the insights in this guide, you can position your business to meet the growing demand for Mexiletine and help advance cardiac care.
Are you interested in sourcing high-quality Mexiletine API or exploring its potential in your pharmaceutical operations?
Contact us today to learn more about our services, pricing, and availability. Let’s collaborate to meet your needs and elevate your business in the pharmaceutical industry.
Disclaimer:
This content is for informational purposes only and is intended for business-to-business communication within the pharmaceutical industry. It is not intended as medical advice. The manufacture, import, and use of API must comply with all applicable laws and regulations in the relevant country or region.
This blog post is informational only and does not constitute medical advice.
Always consult a healthcare professional before starting any new medication or treatment.
We need Mexliletine hcl api with CEP, you have it?
yes, we have it, contact you by email for details.